Sangamo Therapeutics Received U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy

Click here to view

Presentation

Poster: Widespread CNS Tau Knockdown for the Potential Treatment of Alzheimer’s Disease and other Tauopathies

Download PDF